42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => CCMO-WOO-00-58
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 6c335c4c-f025-4a3e-b029-20bffa9f75ae
[Document ID] => 58
[Document naam] => B7. Addendum EudraCt end of trial form dd 09-10-2020
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/CCMO-WOO/ccmo25-14/document/CCMO-WOO-00-58
[Opgeschort] =>
[Definitief ID] => CCMO-WOO-00-58
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/CCMO-WOO/ccmo25-14
[DocumentPublicationDate] => 9 oktober 2020
[DocumentStatusCheckedDate] => 2026-04-28 06:39:52.525994
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-21 22:44:33
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-21 22:44:33
)
Document: CCMO-WOO-00-58
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201009
Geregistreerde documentnaam: B7. Addendum EudraCt end of trial form dd 09-10-2020
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2026-03-10 23:53:07 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Neem dan contact op met Centrale Commissie Mensgebonden Onderzoek. Contactgegevens zijn te vinden op: organisaties.overheid.nl. | 2026-03-10 23:53:07 |
| Request_Omvang publicatie_paginas | 182 | 2026-03-10 23:53:07 |
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/CCMO-WOO/ccmo25-14/file/download/inventory | 2026-03-10 23:53:07 |
| Request_Omvang publicatie | 182 documenten waarvan 162 openbaar gemaakt Inventarislijst | 2026-03-10 23:53:07 |
| DocumentDownload_linkname | Download (pdf, 162.43 KB) | 2025-07-11 05:46:57 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/CCMO-WOO/ccmo25-14/file/download/document/1efdfb24-2b92-6b8c-8988-3d90b3a4337f | 2025-07-11 05:46:57 |
| DocumentDownload_proposed_filename (lokale kopie) | CCMO-WOO-00-58.pdf | 2025-07-11 05:46:57 |
| document_SectionDownloadButton | 1 | 2025-07-11 05:46:57 |
| document_documentPublicationDate | 2020-10-09 | 2025-06-30 05:08:58 |
| document_documentNumber | CCMO-WOO-00-58 | 2025-06-30 05:08:58 |
| document_SectionHTMLDataDivs | 2 | 2025-06-30 05:08:58 |
| document_SectionAbout | 1 | 2025-06-30 05:08:58 |
| About_Datum document | 9 oktober 2020 | 2025-06-30 05:08:58 |
| About_Type bronbestand | PDF, 1 pagina's | 2025-06-30 05:08:58 |
| About_Type bronbestand_paginas | 1 | 2025-06-30 05:08:58 |
| document_SectionDownloadButton | 0 | 2025-06-30 05:08:58 |
| About_Documentnummer | 58 | 2025-06-30 05:08:58 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-30 05:08:58 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-30 05:08:58 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-30 05:08:58 |
| About_Gelakte gegevens_linkhref_2 | https://organisaties.overheid.nl | 2025-06-30 05:08:58 |
| About_Gelakte gegevens_linkname_2 | organisaties.overheid.nl | 2025-06-30 05:08:58 |
| document_SectionRequest | 1 | 2025-06-30 05:08:58 |
| Request_Onderdeel van | Opschorting of voortijdige beëindiging onderzoek vanwege een ernstig ongewenst voorval II | 2025-06-30 05:08:58 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/CCMO-WOO/ccmo25-14 | 2025-06-30 05:08:58 |
| Request_Onderdeel van_linkname_1 | Opschorting of voortijdige beëindiging onderzoek vanwege een ernstig ongewenst voorval II | 2025-06-30 05:08:58 |
| Request_Samenvatting verzoek | Deelbesluit II op het Woo-verzoek inzake opschorting of voortijdige beëindiging van wetenschappelijke onderzoeken vanwege een ernstig ongewenst voorval | 2025-06-30 05:08:58 |
| Request_Periode | Januari 2019 t/m augustus 2024 | 2025-06-30 05:08:58 |
| Request_Type besluit | Woo-besluit | 2025-06-30 05:08:58 |
| Request_Datum besluit | 31 januari 2025 | 2025-06-30 05:08:58 |
| About_Download als | PDF (162.43 KB) | 2025-06-30 05:08:58 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Neem dan contact op met het Centrale Commissie Mensgebonden Onderzoek. Contactgegevens zijn te vinden op: organisaties.overheid.nl. | 2025-06-30 05:08:58 |
| Request_Omvang openbaarmaking | 182 documenten, 1.012 pagina's Inventarislijst | 2025-06-30 05:08:58 |
| Request_Omvang openbaarmaking_documenten | 182 | 2025-06-30 05:08:58 |
| Request_Omvang openbaarmaking_paginas | 1.012 | 2025-06-30 05:08:58 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/CCMO-WOO/ccmo25-14/file/download/inventory | 2025-06-30 05:08:58 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-30 05:08:58 |
| document_documentName | B7. Addendum EudraCt end of trial form dd 09-10-2020 | 2025-06-30 05:08:58 |
| document_documentType | 2025-06-30 05:08:58 |
Archiefversies (4 rijen)
Archiefrij 1 — 2025-11-13 19:19:41
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/CCMO-WOO-00-58.pdf
documentName: CCMO-WOO-00-58.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 166331
documentCompressRatio: 0
documentDateModified: 2025-11-13 19:19:41
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-13 19:19:41
lastSeen: 2025-11-13 19:19:41
text: Annex section D EudrCt end of trial form.
During the course of our trial we encountered several unexpected issues during the GMP production
of the 11C-telmisartan tracer resulting in low yields of the end product. Those issues where always
thoroughly investigated and resolved for that moment. Unfort...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b2db6aeb41caa1e34f7da4948c94a8cb3da4bb03c9f746a1b72a309a95ca1bbb
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_59_13ba3e726be23f94d7fb011a962c3246
textDigestSHA256: f4f0fa241d713df05db3c4830826f47977d1292b838c0dbfb1f6d2c5fa3964d4
ocrTextDigestSHA256: leeg!
extractedId: CCMO-WOO-00-58
Archiefrij 2 — 2025-11-13 17:49:35
fromFile: folder_import
fromFilePath: documenten_files/CCMO-WOO-00-58.pdf
documentName: CCMO-WOO-00-58.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 166331
documentCompressRatio: 0
documentDateModified: 2025-11-13 17:49:35
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-13 17:49:35
lastSeen: 2025-11-13 17:49:35
text: Annex section D EudrCt end of trial form.
During the course of our trial we encountered several unexpected issues during the GMP production
of the 11C-telmisartan tracer resulting in low yields of the end product. Those issues where always
thoroughly investigated and resolved for that moment. Unfort...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b2db6aeb41caa1e34f7da4948c94a8cb3da4bb03c9f746a1b72a309a95ca1bbb
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_59_92e1159a0ea1a93ff386481f0ab4d944
textDigestSHA256: f4f0fa241d713df05db3c4830826f47977d1292b838c0dbfb1f6d2c5fa3964d4
ocrTextDigestSHA256: leeg!
extractedId: CCMO-WOO-00-58
Archiefrij 3 — 2025-09-04 16:12:16
fromFile: CCMO-WOO-ccmo25-14-1f026c98-eba0-66ec-b53e-65673e0af118.zip
fromFilePath: ../../archieven_files/CCMO-WOO-ccmo25-14-1f026c98-eba0-66ec-b53e-65673e0af118.zip
documentName: CCMO-WOO-00-58.pdf
documentType: pdf
documentCompressedSize: 143621
documentSize: 166331
documentCompressRatio: 86.34650185473544
documentDateModified: 2025-05-01 21:02:28
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:12:16
lastSeen: 2025-09-04 16:12:16
text: Annex section D EudrCt end of trial form.
During the course of our trial we encountered several unexpected issues during the GMP production
of the 11C-telmisartan tracer resulting in low yields of the end product. Those issues where always
thoroughly investigated and resolved for that moment. Unf...
noTextDate: 2025-09-04 20:07:10
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b2db6aeb41caa1e34f7da4948c94a8cb3da4bb03c9f746a1b72a309a95ca1bbb
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: CCMO-WOO-ccmo25-14-1f026c98-eba0-66ec-b53e-65673e0af118.zip_54
textDigestSHA256: 0e864d0db5a9a64fb7e5deb91581f96c6e83f527f051f92d759acfbc62f305a3
ocrTextDigestSHA256: leeg!
extractedId: CCMO-WOO-00-58
Archiefrij 4 — 2025-02-18 12:18:10
fromFile: CCMO-WOO-ccmo25-14-586b84ea805c92a099484449e5c9f05b1dda1cd2c17a4d54697e293a01ec5068.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\CCMO-WOO-ccmo25-14-586b84ea805c92a099484449e5c9f05b1dda1cd2c17a4d54697e293a01ec5068.zip
documentName: CCMO-WOO-00-58.
documentType: leeg!
documentCompressedSize: 144832
documentSize: 166331
documentCompressRatio: 87.07456818031515
documentDateModified: 2025-01-31 11:37:32
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:10
lastSeen: 2025-02-18 12:18:10
text: leeg!
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b2db6aeb41caa1e34f7da4948c94a8cb3da4bb03c9f746a1b72a309a95ca1bbb
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 89050
textDigestSHA256: leeg!
ocrTextDigestSHA256: leeg!
extractedId: CCMO-WOO-00-58
(dit is ook een speeltuin)